Insider trade

Officer sold ~$755K of BRKR shares in the open market

Traded Jan 5, 2026 · Filed Jan 6, 2026

Why it stands out

Bruker's EXEC VP&PRES BRUKER NANO INC. sold $755K of Bruker shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer$500K–$1MPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$755,347

Shares × reported transaction price

Timing vs results

63 days after results of Nov 3, 2025, 7 days before results of Jan 12, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−7.3%	+0.1%	−7.4%
30 days	−20.9%	+0.1%	−21.1%
90 days	−30.8%	−4.4%	−26.4%
180 days	+15.7%	+8.9%	+6.8%

Past results only. Not a forecast.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.74 to $50.065, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

9mo ago

Derivative exercise or conversion — not an open-market buy.

Scheduled in advance9mo ago

9mo ago

Derivative exercise or conversion — not an open-market buy.